These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31719677)

  • 1. Transcriptomic analysis implicates necroptosis in disease progression and prognosis in myelodysplastic syndromes.
    Montalban-Bravo G; Class CA; Ganan-Gomez I; Kanagal-Shamanna R; Sasaki K; Richard-Carpentier G; Naqvi K; Wei Y; Yang H; Soltysiak KA; Chien K; Bueso-Ramos C; Do KA; Kantarjian H; Garcia-Manero G
    Leukemia; 2020 Mar; 34(3):872-881. PubMed ID: 31719677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Programmed necroptosis is upregulated in low-grade myelodysplastic syndromes and may play a role in the pathogenesis.
    Zou J; Shi Q; Chen H; Juskevicius R; Zinkel SS
    Exp Hematol; 2021 Nov; 103():60-72.e5. PubMed ID: 34563605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDE4 Differential Expression Is a Potential Prognostic Factor and Therapeutic Target in Patients With Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia.
    Chamseddine AN; Cabrero M; Wei Y; Ganan-Gomez I; Colla S; Takahashi K; Yang H; Bohannan ZS; Garcia-Manero G
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S67-73. PubMed ID: 27521329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomic Signatures of Hypomethylating Agent Failure in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia.
    Darbaniyan F; Zheng H; Kanagal-Shamanna R; Lockyer P; Montalban-Bravo G; Estecio M; Lu Y; Soltysiak KA; Chien KS; Yang H; Sasaki K; Class C; Ganan-Gomez I; Do KA; Garcia-Manero G; Wei Y
    Exp Hematol; 2022 Nov; 115():44-53. PubMed ID: 36150563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligustroflavone reduces necroptosis in rat brain after ischemic stroke through targeting RIPK1/RIPK3/MLKL pathway.
    Zhang YY; Liu WN; Li YQ; Zhang XJ; Yang J; Luo XJ; Peng J
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Sep; 392(9):1085-1095. PubMed ID: 31055628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RIPK3-MLKL-mediated necroinflammation contributes to AKI progression to CKD.
    Chen H; Fang Y; Wu J; Chen H; Zou Z; Zhang X; Shao J; Xu Y
    Cell Death Dis; 2018 Aug; 9(9):878. PubMed ID: 30158627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luteolin ameliorates necroptosis in Glucocorticoid-induced osteonecrosis of the femoral head via RIPK1/RIPK3/MLKL pathway based on network pharmacology analysis.
    Xu X; Fan X; Wu X; Xia R; Liang J; Gao F; Shu J; Yang M; Sun W
    Biochem Biophys Res Commun; 2023 Jun; 661():108-118. PubMed ID: 37099894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Lck inhibitor, AMG-47a, blocks necroptosis and implicates RIPK1 in signalling downstream of MLKL.
    Jacobsen AV; Pierotti CL; Lowes KN; Au AE; Zhang Y; Etemadi N; Fitzgibbon C; Kersten WJA; Samson AL; van Delft MF; Huang DCS; Sabroux HJ; Lessene G; Silke J; Murphy JM
    Cell Death Dis; 2022 Apr; 13(4):291. PubMed ID: 35365636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Ripk1-mediated bone marrow necroptosis leads to myelodysplasia and bone marrow failure in mice.
    Wagner PN; Shi Q; Salisbury-Ruf CT; Zou J; Savona MR; Fedoriw Y; Zinkel SS
    Blood; 2019 Jan; 133(2):107-120. PubMed ID: 30413413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of a necroptosis-associated diagnostic signature for myelodysplastic syndromes based on single-cell RNA-seq and bulk RNA-seq.
    Zhang H; Zhang L; Liang X; Zhang L; Ma B; Li Y; Wang J; Shen Y; Pang Y; Xiong J
    Hereditas; 2024 Oct; 161(1):38. PubMed ID: 39407301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cytosolic heat shock protein 90 and co-chaperone p23 complex activates RIPK3/MLKL during necroptosis of endothelial cells in acute respiratory distress syndrome.
    Yu X; Mao M; Liu X; Shen T; Li T; Yu H; Zhang J; Chen X; Zhao X; Zhu D
    J Mol Med (Berl); 2020 Apr; 98(4):569-583. PubMed ID: 32072232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of keratinocyte necroptosis mediated by RIPK1/RIPK3/MLKL provides a protective effect against psoriatic inflammation.
    Duan X; Liu X; Liu N; Huang Y; Jin Z; Zhang S; Ming Z; Chen H
    Cell Death Dis; 2020 Feb; 11(2):134. PubMed ID: 32075957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neurotoxicant PCB-95 by increasing the neuronal transcriptional repressor REST down-regulates caspase-8 and increases Ripk1, Ripk3 and MLKL expression determining necroptotic neuronal death.
    Guida N; Laudati G; Serani A; Mascolo L; Molinaro P; Montuori P; Di Renzo G; Canzoniero LMT; Formisano L
    Biochem Pharmacol; 2017 Oct; 142():229-241. PubMed ID: 28676433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc finger protein 91 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation.
    Zhong Y; Zhang ZH; Wang JY; Xing Y; Ri MH; Jin HL; Zuo HX; Li MY; Ma J; Jin X
    Toxicol Lett; 2022 Mar; 356():75-88. PubMed ID: 34942311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FKBP12 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation.
    Wang Z; Feng J; Yu J; Chen G
    J Cell Sci; 2019 May; 132(10):. PubMed ID: 31028177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspase-8, receptor-interacting protein kinase 1 (RIPK1), and RIPK3 regulate retinoic acid-induced cell differentiation and necroptosis.
    Someda M; Kuroki S; Miyachi H; Tachibana M; Yonehara S
    Cell Death Differ; 2020 May; 27(5):1539-1553. PubMed ID: 31659279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RIPK1-RIPK3-MLKL-Associated Necroptosis Drives
    Barbosa LA; Fiuza PP; Borges LJ; Rolim FA; Andrade MB; Luz NF; Quintela-Carvalho G; Lima JB; Almeida RP; Chan FK; Bozza MT; Borges VM; Prates DB
    Front Immunol; 2018; 9():1818. PubMed ID: 30154785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation.
    Lin J; Kumari S; Kim C; Van TM; Wachsmuth L; Polykratis A; Pasparakis M
    Nature; 2016 Dec; 540(7631):124-128. PubMed ID: 27819681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury.
    Newton K; Dugger DL; Maltzman A; Greve JM; Hedehus M; Martin-McNulty B; Carano RA; Cao TC; van Bruggen N; Bernstein L; Lee WP; Wu X; DeVoss J; Zhang J; Jeet S; Peng I; McKenzie BS; Roose-Girma M; Caplazi P; Diehl L; Webster JD; Vucic D
    Cell Death Differ; 2016 Sep; 23(9):1565-76. PubMed ID: 27177019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposite Effects of Apoptotic and Necroptotic Cellular Pathways on Rotavirus Replication.
    Soliman M; Seo JY; Baek YB; Park JG; Kang MI; Cho KO; Park SI
    J Virol; 2022 Jan; 96(1):e0122221. PubMed ID: 34668777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.